profit from every $100 of sales.
$0$100
Encompass Health
$140.99+0.11% today
+23.4% in 1 year
1-year low $93.831-year high $142.51
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $24.43 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Encompass Health sold, what it kept, and what it did with the cash.
Sales went from $4.35 billion in 2022 to $5.94 billion in 2025, with $566 million of profit last year.
SalesProfit
Encompass Health handed back 52% of the cash it generated last year.
Buybacks $158M$71M
Free cash flow 2025$439M
Bought back its own shares$158M
Paid as dividends$71M
Cash vs. debt$72M vs. $2.7B
Encompass Health vs. similar companies
Encompass Health grows the fastest of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Encompass Health | 24.4× · Fair price | ||
 Tenet Healthcare | 16.2× · Fair price | ||
 Solventum | 9.7× · Cheap | ||
 Fresenius Medical Care AG & Co. KGaA | 10.6× · Cheap | ||
 Universal Health Services | 7.5× · Cheap |
Compare Encompass Health with Select Medical
AI analysis
An AI analyst reads Encompass Health's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 3,566 | 4,015 | 4,349 | 4,801 | 5,373 | 5,935 | |
| – | – | 1,753 | 1,983 | 2,233 | 5,681 | |
| – | – | 630 | 732 | 865 | 1,053 | |
| 740 | 889 | 870 | 1,025 | 1,187 | 1,404 | |
| 284 | 412 | 271 | 352 | 456 | 566 | |
| 2.85 | 4.11 | 2.70 | 3.47 | 4.46 | 5.54 | |
| – | – | 40.3% | 41.3% | 41.6% | 95.7% | |
| – | – | 14.5% | 15.2% | 16.1% | 17.7% | |
| 8.0% | 10.3% | 6.2% | 7.3% | 8.5% | 9.5% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 6,446 | 6,865 | 5,637 | 6,102 | 6,535 | 7,090 |
| Cash | 186 | 49 | 22 | 69 | 85 | 72 |
| Total debt | 3,543 | 3,530 | 2,992 | 2,933 | 2,714 | 2,714 |
| Total liabilities | 4,444 | 4,466 | 3,775 | 3,805 | 3,686 | 3,814 |
| 1,588 | 1,911 | 1,310 | 1,648 | 2,067 | 2,438 | |
| 100 | 100 | 100 | 101 | 102 | 102 | |
| 8.3% | 9.7% | 11.5% | 12.9% | 14.7% | 16.5% | |
| 17.9% | 21.6% | 20.7% | 21.4% | 22.0% | 23.2% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 705 | 716 | 706 | 851 | 1,003 | 1,176 | |
| 393 | 525 | 584 | 583 | 643 | 736 | |
| 312 | 191 | 122 | 268 | 360 | 439 | |
| Dividends paid | 112 | 112 | 99 | 60 | 63 | 71 |
| 6 | 0 | 0 | 0 | 31 | 158 | |
| 26 | 29 | 29 | 51 | 48 | 57 |
Valuation
- 24.4×
- 23.8×
- 1.72
- 4.2×
- 2.3×
- 31.5×
- 11.7×
- 3.2%
- 4.1%
- 0.7%
Profitability
- 95.7%
- 17.7%
- 9.5%
- 23.8%
- 13.3%
- 8.4%
- 25.3%
- 8.3%
- 16.9%
- –
Growth
- +10.7%
- +14.2%
- +21.9%
- −4.7%
- +0.4%
Financial health
- 1.8×
- 1.11
- 38.1%
- 8.8×
- 1.17
- 1.17
- 0.83
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 18%of 946
Top 28%of 871
Top 41%of 563
Bottom 48%of 867
Top 33%of 986
What analysts expect
- Average price target
- $140.00
- Range
- $140.00 – $140.00
- 2 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 1.60 | 1.51 | +6.0% |
| Feb 5, 2026 | 1.46 | 1.29 | +13.2% |
| Oct 29, 2025 | 1.23 | 1.19 | +3.4% |
| Aug 4, 2025 | 1.40 | 1.23 | +13.8% |
| Apr 24, 2025 | 1.37 | 1.19 | +15.1% |
| Feb 6, 2025 | 1.17 | 1.05 | +11.4% |
| Oct 28, 2024 | 1.03 | 0.94 | +9.6% |
| Aug 5, 2024 | 1.11 | 1.01 | +9.9% |
0.7%of the share price, paid each year
On $1,000 invested$7a year at today's yield, before tax
−4.7%2020 to 2025
Raised1 yearin a row, in our data
Paid per share, each year
$0.70 in 2015 → $0.70 in 2025
How safe it looks
12.6% of its profit
Room to growStretchedMore than it earns: 16.2%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
53No pass
Benjamin Graham
44No pass
Philip Fisher
65Pass
Peter Lynch
53No pass
Joel Greenblatt
38No pass
Charlie Munger
48No pass
Terry Smith
46No pass
Questions about Encompass Health
Is Encompass Health a good stock to buy?
A solid business at a fair price. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Encompass Health AI analysis
What does Encompass Health do?
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. It is in Medical - Care Facilities, based in Birmingham, AL, United States, with 29,599 employees.
Does Encompass Health pay a dividend?
Yes. At today's price the dividend is 0.7% a year, about 13% of its yearly profit. In 2025 it paid out $71.1 million in dividends.
Is Encompass Health stock halal?
Yes. Encompass Health passes our halal screen: its business is permitted and its debt is 20% of its market value, under the 30% limit. How we check
How has Encompass Health stock done over the past year?
Up 23.4% over the past twelve months, to $140.99. It traded between $93.83 and $142.51, close to its high.
Who are Encompass Health's competitors?
The largest listed companies in the same industry are Tenet Healthcare, Solventum, Fresenius Medical Care AG & Co. KGaA and Universal Health Services. The peers table on this page compares their profit, growth and price with Encompass Health's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.